SMILES,Updated_SMILES,Property,Rationale
O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3ccccc3Cl)CC2=O)cc1Cl)c1ccc(NCC2CC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3ccccc3Cl)CC2=O)cc1Cl)c1ccc(NCC2CC2)cc1C#N,[Absorption/Caco-2 (logPaap)] Predictions,"The nitro group was replaced with a cyano group to reduce polarity and potentially improve Caco-2 permeability, addressing the critical weakness of poor absorption."
CC(C)CNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C)C(=O)C3)c(Oc3cnc(Cl)s3)c2)cc1[N+](=O)[O-],CC(C)CNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C)C(=O)C3)c(Oc3cnc(Cl)s3)c2)cc1C#N,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the nitro group with a cyano group, which is less polar and can potentially improve the Caco-2 permeability, addressing the poor absorption issue."
O=C(NS(=O)(=O)c1ccc(N2CCN(CC3CCC3)CC2=O)cc1)c1ccc(Cl)nc1Cl,O=C(Nc1ccc(N2CCN(CC3CCC3)CC2=O)cc1)c1ccc(Cl)nc1Cl,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the sulfonamide group with a less polar amide group, which can potentially improve the molecule's permeability and absorption profile by reducing the number of polar groups."
CN(C)CCNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C/C=C/c4ccccc4)CC3)c([N+](=O)[O-])c2)cc1F,CN(C)CCNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C/C=C/c4ccccc4)CC3)c(c2)C#N)cc1F,[Toxicity/hERG Blockers] Predictions,"The modification involves replacing the nitro group with a cyano group, which is less lipophilic. This change aims to reduce the molecule's lipophilicity and potentially decrease its hERG channel inhibition, addressing the critical toxicity concern."
COc1ccccc1S(=O)(=O)NC(=O)c1ccc(N2CCN(C)C(=O)C2)c(Oc2cnc(Cl)c(Cl)c2)c1,COc1ccccc1S(=O)(=O)NC(=O)c1ccc(N2CCN(C)C(=O)C2)c(Oc2cnc(Cl)c(Cl)c2)c1,[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES string is invalid, and attempts to correct it have failed. Returning the original SMILES."
O=C(NS(=O)(=O)c1ccc(NC(=O)C2CC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(CCO)CC2)c(Cl)c1,O=C(NS(=O)(=O)c1ccc(NC(=O)C2CC2)cc1)c1ccc(N2CCN(CCO)CC2)c(Cl)c1,[Absorption/Caco-2 (logPaap)] Predictions,"Removing the nitro group is expected to improve absorption by reducing the molecular weight and increasing lipophilicity, which can enhance permeability and overall absorption properties."
O=C(NS(=O)(=O)c1ccc(N2CCOCC2=O)c(Cl)c1)c1ccc(N2CCOCC2)cc1,O=C(Nc1ccc(N2CCOCC2=O)c(Cl)c1)c1ccc(N2CCOCC2)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"Replaced the sulfonamide group with a less polar amide to enhance absorption properties, particularly Caco-2 permeability."
O=C(NS(=O)(=O)c1ccc(F)cc1)c1ccc(N2CCN(CC3CC3)CC2=O)cc1Oc1cncc(Cl)c1,O=C(NC)c1ccc(N2CCN(CC3CC3)CC2=O)cc1Oc1cncc(Cl)c1,[Absorption/Caco-2 (logPaap)] Predictions,"Replaced the sulfonamide group with a methyl group to reduce hydrogen bonding, potentially enhancing permeability and absorption."
O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3cccs3)CC2=O)cc1)c1ccc(NCC2CC2)c(Cl)c1,O=C(Oc1ccc(N2CCN(Cc3cccs3)CC2=O)cc1)c1ccc(NCC2CC2)c(Cl)c1,[Absorption/Caco-2 (logPaap)] Predictions,"Replacing the sulfonamide group with an ether linkage reduces the number of hydrogen bond donors and acceptors, potentially improving the molecule's permeability and absorption profile."
O=C(NS(=O)(=O)c1ccc(N2CCN(C/C=C/c3ccccc3)CC2=O)cc1)c1ccc(NCC2CC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(N2CCN(C/C=C/c3ccccc3)CC2=O)cc1)c1ccc(NCC2CC2)c([N+](=O)[O-])c1,[Absorption/Caco-2 (logPaap)] Predictions,"All modification attempts to improve Caco-2 permeability resulted in invalid SMILES, so the original structure is retained."
O=C(NS(=O)(=O)c1ccc(N2CCN(CC(F)(F)F)CC2)cc1)c1ccc(NCC2CC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(N2CCN(CC(F)(F)F)CC2)cc1)c1ccc(NCC2CC2)cc1C#N,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involved replacing the nitro group with a cyano group, which is less polar. This change aims to improve the molecule's permeability by reducing its overall polarity, potentially enhancing its absorption profile."
N#Cc1cc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4CC4)CC3)cc2Oc2cnccc2Cl)ccc1F,N#Cc1cc(C(=O)NC(=O)c2ccc(N3CCN(CC4CC4)CC3)cc2Oc2cnccc2Cl)ccc1F,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the sulfonamide group with a carbonyl group to reduce polarity and potentially improve Caco-2 permeability, addressing the critical weakness of poor absorption."
CCCc1ccccc1NC(=O)c1ccc(N2CCN(CC3CCCC3)[C@@H](C)Oc3cnc(N)c(Cl)c32)cc1[N+](=O)[O-],CCCc1ccccc1NC(=O)c1ccc(N2CCN(CC3CCCC3)[C@@H](C)Oc3cnc(N)c(Cl)c32)cc1[N+](=O)[O-],[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES string is invalid, and attempts to modify it have failed. Please provide a valid SMILES string for further analysis."
O=C(NS(=O)(=O)c1ccc(-c2noc(=O)[nH]2)cc1)c1ccc(N2CCN(CC(F)F)CC2)c(F)c1,O=C(Nc1ccc(-c2noc(=O)[nH]2)cc1)c1ccc(N2CCN(CC(F)F)CC2)c(F)c1,[Absorption/Caco-2 (logPaap)] Predictions,Replaced the sulfonamide group with a less polar amide to potentially improve permeability and absorption.
O=C(NS(=O)(=O)c1ccc(N2CCOCC2=O)cc1)c1ccc(N2CCN(C(=O)OC3CCCC3)CC2)c(F)c1,O=C(NS(=O)(=O)c1ccc(N2CCOCC2)cc1)c1ccc(N2CCN(C(=O)OC3CCCC3)CC2)c(F)c1,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves removing the carbonyl group from the morpholine ring, which may reduce the polarity and size of the molecule, potentially improving its Caco-2 permeability and thus its oral bioavailability."
O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3ccccn3)CC2)cc1Cl)c1ccc(NCC2CC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3ccccn3)CC2)cc1Cl)c1ccc(NCC2CC2)c([H])c1,[Absorption/Caco-2 (logPaap)] Predictions,"The nitro group was replaced with a hydrogen atom to reduce the polar surface area and potentially improve Caco-2 permeability, addressing the critical weakness of poor absorption potential."
CC(C)(C)OC(=O)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CCO)CC3)c(F)c2)cc1[N+](=O)[O-],CC(C)(C)OC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(CCO)CC3)c(F)c2)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"Replaced the nitro group with a hydrogen atom to reduce polarity and molecular size, potentially improving permeability."
CCC(C)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(Cl)s3)c([N+](=O)[O-])c2)C(Oc2cnc(Cl)s2)C1,CCC(C)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(Cl)s3)cc2)C(Oc2cnc(Cl)s2)C1,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involved removing the nitro group, which is known to contribute to poor permeability due to its high polarity. This change is expected to improve the molecule's permeability and absorption characteristics."
O=C(NS(=O)(=O)c1ccc(OCC(F)(F)F)cc1)c1ccc(N2CCN(CC(F)F)CC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(OCCOC)cc1)c1ccc(N2CCN(CC(F)F)CC2)c([N+](=O)[O-])c1,[Toxicity/hERG Blockers] Predictions,"Replacing the trifluoromethyl group with a methoxy group reduces lipophilicity, potentially decreasing hERG binding and improving the safety profile."
O=C(NS(=O)(=O)c1ccc(N2CCOCC2)c([N+](=O)[O-])c1)c1ccc(C(F)(F)F)nc1O,O=C(NS(=O)(=O)c1ccc(N2CCOCC2)cc1C#N)c1ccc(C(F)(F)F)nc1O,[Toxicity/Liver Injury I (DILI)] Predictions,"The original SMILES contained a nitro group, which can be metabolically activated to toxic intermediates, contributing to liver toxicity. Replacing the nitro group with a cyano group (C#N) can potentially reduce this risk."
O=C(NS(=O)(=O)c1ccc(N2CCN(c3ccc(Cl)s3)CC2=O)cc1)c1ccc(NC2CCCCC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(N2CCN(c3ccc(Cl)s3)CC2=O)cc1)c1ccc(NC2CCCCC2)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"The nitro group was removed to reduce polarity and potentially improve Caco-2 permeability, addressing the critical weakness of poor absorption."
O=C(NS(=O)(=O)c1ccc(N2CCOCC2)c(Cl)c1)c1ccc(N2CCOCC2=O)cc1,O=C(NS(=O)(=O)c1ccc(N2CCOCC2)c(Cl)c1)c1ccc(N2CCOCC2=O)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES is returned due to repeated invalid modification attempts. The critical weakness identified was poor absorption properties, specifically low Caco-2 permeability."
CCC(=O)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C)CC3)c(Oc3cncn3C)c2)cc1C,CCC(=O)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C)CC3)c(Oc3cncn3C)c2)cc1C,[Absorption/Caco-2 (logPaap)] Predictions,The original SMILES is returned as all modification attempts resulted in invalid SMILES.
COc1cccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C[C@@H]4CC[C@H](C)O4)C3=O)c3[nH]c(C#N)cc23)c1,COc1cccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(C[C@@H]4CC[C@H](C)O4)C3)c3[nH]c(C#N)cc23)c1,[Absorption/Caco-2 (logPaap)] Predictions,Removed the carbonyl group from the piperazine ring to reduce polar surface area and potentially improve permeability.
CC(C)NC(=O)c1ccc(N2CCN(CC3CC3)[C@@H](Oc3cnc(Cl)s3)C2=O)cc1[N+](=O)[O-],CC(C)NC(=O)c1ccc(N2CCN(CC3CC3)[C@@H](Oc3cnc(Cl)s3)C2=O)cc1C#N,[Toxicity/AMES Mutagenesis] Predictions,"The modification involves replacing the nitro group with a cyano group to reduce mutagenicity, addressing the AMES Mutagenesis prediction."
Cc1ncsc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC(C)(C)C)CC2)cc1[N+](=O)[O-],Cc1ncsc1S(=O)(=O)NC(=O)c1ccc(N2CCN(CC)CC2)cc1[N+](=O)[O-],[Absorption/Caco-2 (logPaap)] Predictions,"The modification involved removing the bulky tert-butyl group and replacing it with an ethyl group, which can potentially reduce steric hindrance and improve permeability, thereby enhancing absorption properties."
O=C(NS(=O)(=O)c1ccc(N2CCN(C3CCCCC3)CC2=O)cc1)c1ccc(NCC2CC2)c(Cl)c1,O=C(NS(=O)(=O)c1ccc(N2CCN(C3CCCCC3)CC2=O)cc1)c1ccc(NCC2CC2)c(Cl)c1,[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES string is invalid, and multiple modification attempts have failed. Returning the original SMILES as per the protocol."
O=C(NS(=O)(=O)c1ccc(N2CCN(CC3CCCO3)CC2)c([N+](=O)[O-])c1)c1ccc(N2CCOCC2)c(F)c1,O=C(NS(=O)(=O)c1ccc(N2CCN(CC3CCCO3)CC2)cc1C#N)c1ccc(N2CCOCC2)c(F)c1,[Toxicity/AMES Mutagenesis] Predictions,"The nitro group in the original SMILES is a known contributor to toxicity, particularly mutagenicity. By replacing the nitro group with a cyano group, which is generally less toxic, the overall toxicity of the molecule may be reduced, potentially improving its safety profile as a drug candidate."
O=C(NS(=O)(=O)c1ccc(N2CCNCC2)c(O)c1)c1ccc(N2CCOCC2)c(Cl)c1,O=C(NS(=O)(=O)c1ccc(N2CCNCC2)c(C)c1)c1ccc(N2CCOCC2)c(Cl)c1,[Absorption/Caco-2 (logPaap)] Predictions,Replaced the hydroxyl group with a methyl group to reduce polarity and potentially improve permeability.
COc1cc(N2CCOCC2)ccc1S(=O)(=O)NC(=O)c1ccc(N2CCN(C)CC2)c([N+](=O)[O-])c1,COc1cc(N2CCOCC2)ccc1S(=O)(=O)NC(=O)c1ccc(N2CCN(C)CC2)c(C#N)c1,Toxicity/AMES Mutagenesis,"The modification involves replacing the nitro group ([N+](=O)[O-]) with a cyano group (C#N). Nitro groups are often associated with mutagenicity, and replacing it with a cyano group can potentially reduce the mutagenic risk, addressing the toxicity concern."
O=C(NS(=O)(=O)c1ccc(N2CCN(CC3CCC3)CC2)cc1)c1ccc(N2CCOCC2)cc1F,O=C(Nc1ccc(N2CCN(CC3CCC3)CC2)cc1)c1ccc(N2CCOCC2)cc1F,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the sulfonamide group with a less polar amide group, which can potentially improve the molecule's permeability and absorption profile by reducing its overall polarity."
Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4CC4)CC3)cc2Oc2cncc(Cl)c2)cc1,Nc1ccc(Oc2ccc(N3CCN(CC4CC4)CC3)cc2Oc2cncc(Cl)c2)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the sulfonamide group with an ether linkage, which reduces the polarity of the molecule. This change is expected to improve the Caco-2 permeability, thereby enhancing the absorption characteristics of the drug candidate."
O=C(O)c1ccc(N2CCN(c3ccc([N+](=O)[O-])c(Oc4cnco4)c3)CC2)cc1[N+](=O)[O-],O=C(O)c1ccc(N2CCN(c3ccc(Oc4cnco4)c3)CC2)cc1,[Toxicity/AMES Mutagenesis] Predictions,Removed nitro groups to reduce mutagenicity and improve safety profile.
CCC1CN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC(=O)O)c(Cl)c3)c(O)c2)CCN1,CCC1CN(c2ccc(C(=O)NC(=O)c3ccc(NCC(=O)O)c(Cl)c3)c(O)c2)CCN1,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the sulfonamide group with an amide group, which is less polar. This change is aimed at improving the molecule's permeability by reducing its polar surface area, potentially enhancing its '[Absorption/Caco-2 (logPaap)] Predictions'."
CCCS(=O)(=O)NC(=O)c1ccc(N2CCN(C)CC2=O)c(Oc2cnc(Cl)c(Cl)c2)c1,CCCOC(=O)NC(=O)c1ccc(N2CCN(C)CC2=O)c(Oc2cnc(Cl)c(Cl)c2)c1,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the sulfonamide group with an ether group, which is less polar and could potentially improve the permeability of the molecule by reducing the number of hydrogen bond acceptors and increasing lipophilicity."
Cc1cc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC(=O)O)CC3C)c(Oc3cnc(Cl)c(Cl)c3)c2)co1,Cc1cc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC(=O)O)CC3C)c(Oc3cnc(Cl)c(Cl)c3)c2)co1,[Toxicity/hERG Blockers] Predictions,"Despite attempts to modify the structure to reduce hERG toxicity, the modifications resulted in invalid SMILES. Therefore, the original SMILES is retained."
O=C(NS(=O)(=O)c1ccc(N2CCN(CC3CC3)CC2=O)cc1Cl)c1ccc(NCC2CCOC2)cc1,O=C(NS(=O)(=O)c1ccc(N2CCN(CC3CC3)CC2=O)cc1Cl)c1ccc(NCC2CCOC2)cc1C,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involves replacing the chlorine atom with a methyl group, which can potentially reduce the polarity and slightly increase lipophilicity, thereby improving the Caco-2 permeability."
COc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccc(Br)cc4)CC3)c([N+](=O)[O-])c2)cc1O,COc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccc(Br)cc4)CC3)c([N+](=O)[O-])c2)cc1O,[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES is returned as the modification attempts were unsuccessful. The critical weakness identified was poor permeability, indicated by the '[Absorption/Caco-2 (logPaap)] Predictions' value of -5.38."
CCCC(C)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(Cl)c(Cl)c3)c(Oc3cnc[nH]3)c2)CC1,CCCC(C)N1CCN(c2ccc(C(=O)OCC)c(Oc3cnc[nH]3)c2)CC1,[Absorption/Caco-2 (logPaap)] Predictions,"Replaced the sulfonamide group with an ether to reduce hydrogen bonding potential, potentially improving permeability and absorption."
CCCCNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC)CC3)c(Oc3cncnc3C)c2)cc1[N+](=O)[O-],CCCCNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC)CC3)c(Oc3cncnc3C)c2)cc1C,[Toxicity/AMES Mutagenesis] Predictions,"The modification involved replacing the nitro group with a methyl group, which is less likely to contribute to mutagenicity. This change aims to reduce the potential mutagenic properties of the molecule, addressing its critical weakness as a drug candidate."
COc1ccc(NC(=O)c2ccc(N3CCN(CC4CCC(C)(C)O4)CC3)cc2Oc2ccc(F)nc2)cc1,COc1ccc(NC(=O)c2ccc(N3CCN(CC4CCC(C)(C)O4)CC3)cc2Oc2ccc(F)nc2)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES is returned as the modification attempts were unsuccessful. The critical weakness identified was poor permeability, indicated by the '[Absorption/Caco-2 (logPaap)] Predictions' value of -4.92."
CN(C)S(=O)(=O)NC(=O)c1ccc(N2CCN(C[C@H]3CC[C@@H](C(=O)O)CC3)[C@@H]2Oc2cnc(N)cc2Cl)cc1,CN(C)S(=O)(=O)NC(=O)c1ccc(N2CCN(C[C@H]3CC[C@@H](C(=O)O)CC3)[C@@H]2Oc2cnc(N)cc2Cl),[Absorption/Caco-2 (logPaap)] Predictions,The original SMILES is returned due to repeated invalid modifications.
C=CCN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(OC)c(SC)c3)c(Oc3cnc(Cl)[nH]3)c2)CC1,C=CCN1CCN(c2ccc(C(=O)Nc3ccc(OC)c(SC)c3)c(Oc3cnc(Cl)[nH]3)c2)CC1,[Absorption/Caco-2 (logPaap)] Predictions,"Removing the sulfonamide group reduces polarity, potentially improving permeability and absorption."
O=C(NS(=O)(=O)c1ccc(N2CCN(c3ccccn3)CC2=O)cc1NCC1CC1)c1ccc(Cl)s1,O=C(NS(=O)(=O)c1ccc(N2CCN(c3ccccn3)CC2=O)cc1NCC1CC1)c1ccc(Cl)s1,[Absorption/Caco-2 (logPaap)] Predictions,The original SMILES is returned as the modification attempts failed to produce a valid structure.
O=C(NS(=O)(=O)c1ccc(N2CCOCC2=O)c(Cl)c1)c1ccc(N2CCOCC2)c(Cl)c1,O=C(NS(=O)(=O)c1ccc(N2CCOCC2=O)c(Cl)c1)c1ccc(N2CCOCC2)c(Cl)c1,[Absorption/Caco-2 (logPaap)] Predictions,"The original SMILES is invalid, and I am unable to propose a modification without a valid starting structure.
'''"
O=C(NS(=O)(=O)c1ccc(F)c(Cl)c1)NS(=O)(=O)c1ccc(Oc2cncnc2)c(Cl)c1,O=C(NS(=O)(=O)c1ccc(F)c(Cl)c1)NS(=O)(=O)c1ccc(Oc2cncnc2)c(F)c1,[Toxicity/Liver Injury I (DILI)] Predictions,"The modification involves replacing one of the chlorine atoms with a fluorine atom. Fluorine is often used to reduce metabolic liabilities and potentially decrease toxicity, including hepatotoxicity, while maintaining the molecule's activity."
O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3cccs3)CC2=O)cc1)c1ccc(NC2CCCCC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(N2CCN(Cc3cccs3)CC2)cc1)c1ccc(NC2CCCCC2)c([N+](=O)[O-])c1,[Absorption/Caco-2 (logPaap)] Predictions,"The modification involved removing the ketone group from the piperazine ring, which could potentially reduce the molecular size and polarity, thereby improving the permeability as indicated by the Caco-2 prediction."
CN(C)c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC(=O)O)CC3)c(Oc3cnccc3Cl)c2)cc1,CN(C)c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC(=O)O)CC3)c(Oc3cnccc3Cl)c2)cc1,[Absorption/Caco-2 (logPaap)] Predictions,"All modification attempts to improve absorption resulted in invalid SMILES, so the original structure is retained."
O=C(NS(=O)(=O)c1ccc(F)cc1)c1ccc(N2CCN(Cc3ccncc3)CC2)c([N+](=O)[O-])c1,O=C(NS(=O)(=O)c1ccc(F)cc1)c1ccc(N2CCN(Cc3ccncc3)CC2)c(C#N)c1,[Toxicity/hERG Blockers] Predictions,"The modification involves replacing the nitro group with a cyano group, which is expected to reduce the molecule's lipophilicity and potentially decrease its hERG channel inhibition, thereby improving its safety profile as a drug candidate."
